News

The protein ADAM17 appears to serve as a switch for chronic obstructive pulmonary disease (COPD), a study in a mouse model of emphysema reports, promoting COPD’s development when activated and alleviating disease features when deficient. An increase in active ADAM17 is also…

The European Commission has approved AstraZeneca‘s triple combination therapy Trixeo Aerosphere as a maintenance treatment for chronic obstructive pulmonary disease (COPD). The approval, which follows a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), covers the therapy’s use in adults with moderate-to-severe COPD…

The inflammatory biomarkers FeNO and EOS can be used as indicators to distinguish people with chronic obstructive pulmonary disease (COPD) from those with COPD combined with asthma, a study has found.  These biomarkers’ diagnostic value, however, was…

The COPD Foundation and Blue Marble Health have partnered to promote pulmonary rehabilitation through a virtual program for people with chronic obstructive pulmonary disease (COPD) during the COVID-19 pandemic. “We hope to enable participation and maximize the benefits of virtual pulmonary rehabilitation by providing a…

After a review of current evidence by a panel of experts, the American Thoracic Society (ATS) has published new recommended guidelines for the use of oxygen therapy by people with chronic obstructive pulmonary disease (COPD) and other long-term…

Nuvaira’s targeted lung denervation (TLD) therapy lowers the risk of hospitalization due to exacerbations in people with chronic obstructive pulmonary disease (COPD), Phase 2 trial data show, according to a company press release. A new clinical study, called AIRFLOW-3 (NCT03639051), is currently recruiting COPD patients at multiple…

A new Alexa healthcare skill, called the Emmi Care Plan, provides a voice service that allows patients to easily remain in contact with their healthcare providers while recovering at home after being discharged from the hospital. It’s being launched by Wolters Kluwer, Health, a global leader in providing…

Use of electronic cigarettes (e-cigarettes) is associated with an increased risk of respiratory diseases, including chronic obstructive pulmonary disease (COPD), among young adults, irrespective of other tobacco product use, a large U.S.-based study shows. Compared to healthy people, those currently using e-cigarettes, commonly called vaping, had a 43% increased…

Enrollment in a clinical trial evaluating the mechanism of action of RejuvenAir Metered Cryospray, CSA Medical’s investigational approach for the treatment of chronic bronchitis, has already passed the halfway point, the company announced. However, adults ages 40-79 with chronic bronchitis are still being recruited at the University…

Inhibiting a protein called lymphotoxin beta receptor (LTβR) could be an effective therapeutic strategy for chronic obstructive pulmonary disease (COPD), new research suggests. The findings were published in Nature, in the study “Inhibition of LTβR signalling activates WNT-induced regeneration in lung.” COPD is characterized by the…